News Focus
News Focus
Replies to #29590 on Biotech Values
icon url

DewDiligence

06/04/06 1:31 PM

#29592 RE: randychub #29590

>Antisoma also announces that it has regained all rights to AS1404 from Roche, and plans to take the drug forward promptly into a phase III trial in lung cancer.<

It would have been nice to have some detail on the re-acquisition transaction. You generally don’t get something for nothing in this business.
icon url

DewDiligence

06/05/06 10:39 AM

#29636 RE: randychub #29590

> Antisoma reports survival advantage for AS1404 in lung cancer and regains product rights<

In biotech, “regains product rights” is a euphemism for getting dumped by a partner.

Antisoma is down 15% today.